Skip to content

Effect of “Pardihan” syrup on platelet count

Effect of “Pardihan” syrup on platelet count: a randomized double-blind placebo controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20081024001391N3
Enrollment
32
Registered
2021-06-09
Start date
2021-04-09
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with thrombocytopenia. Thrombocytopenia, unspecified

Interventions

Intervention 1: Intervention group: Pardihan medicine is a combination of grape juice, apple and basil produced by Sanabel Daroo Company with a license from the Food and Drug Administration of the cou

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with a diagnosis of thrombocytopenia Signing a informed consent form Age over 18 years

Exclusion criteria

Exclusion criteria: History of allergy to medicinal plants components Use of nplate drug

Design outcomes

Primary

MeasureTime frame
Platelet counts and hemoglobin. Timepoint: Take the drug for 4 weeks. Measurements are taken after 2, 4 and 6 weeks. Method of measurement: Blood test (CBC).

Secondary

MeasureTime frame
Quality of Life. Timepoint: Before starting the study; After 6 weeks (end of study). Method of measurement: World Health Organization Quality of Life Questionnaire 26 questions.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Naseri

Shahed University

naseri@shahed.ac.ir+98 21 6646 4320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026